Publication:
Is there a role for sulfasalazine in the treatment of alopecia areata?

dc.contributor.authorsBakar, Oezguer; Gurbuz, Oya
dc.date.accessioned2022-03-10T15:25:01Z
dc.date.accessioned2026-01-11T15:10:25Z
dc.date.available2022-03-10T15:25:01Z
dc.date.issued2007
dc.description.abstractPromising results have been published in the past with the use of sulfasalazine in alopecia areata. We also observed maintenance of hair growth in refractory alopecia areata patients who were treated with sulfasalazine in combination with oral corticosteroids for 2 to 6 months and sulfasalazine alone for 4 to 12 months while steroids were being tapered. We believe that, because of the small series reported herein, additional larger prospective studies should be conducted to validate these results.
dc.identifier.doi10.1016/j.jaad.2006.10.980
dc.identifier.eissn1097-6787
dc.identifier.issn0190-9622
dc.identifier.pubmed17610992
dc.identifier.urihttps://hdl.handle.net/11424/220065
dc.identifier.wosWOS:000249695600022
dc.language.isoeng
dc.publisherMOSBY-ELSEVIER
dc.relation.ispartofJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCYCLOSPORINE
dc.subjectTHERAPY
dc.subjectEFFICACY
dc.subjectACID
dc.titleIs there a role for sulfasalazine in the treatment of alopecia areata?
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage706
oaire.citation.issue4
oaire.citation.startPage703
oaire.citation.titleJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
oaire.citation.volume57

Files